Views & Analysis | Perspectives on pharma industry issues

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Market Access

Sponsored

The pre-commercial case for connecting data before acquiring...

For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Patients

pharmaphorum podcast Episode 281 - Cecilia Caetano, Bayer

Sponsored

Menopause is an urgent global health issue: Bayer’s Cecilia ...

Articles

Forging more secure links in the pharma-biotech supply chain

In this article, Katarina Sapeta discusses some of the security challenges in the pharmaceutical industry, such as counterfeit drugs, and what’s being done to overcome these issues. In recent years we’ve witnessed an aggressive structural reorganization in almost all areas of the Big Pharma / biotech sector, in an...

Articles

Vietnam pharmaceutical market update 2013

Ames Gross provides an update on the Vietnamese pharmaceutical market. Vietnam is one of the fastest growing pharmaceutical markets in Asia. In 2012, Vietnam’s drug market was worth almost $3 billion...

Articles

Executive perspectives: Dr Roch Doliveux

As the pharma industry increasingly talks about being patient focussed, Paul Tunnah finds out what this specifically means for Dr Roch Doliveux as he steers a new course for UCB. The man at the helm of biopharmaceutical company UCB is in an ebullient mood following the release of the company’s full year 2012 results. Revenue growth of…

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Sales & Marketing

Female pharmacist with male patient in pharmacy

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital